PH22541A - Octahydro-oxazolo(4,5-g)quinolines - Google Patents

Octahydro-oxazolo(4,5-g)quinolines

Info

Publication number
PH22541A
PH22541A PH32596A PH32596A PH22541A PH 22541 A PH22541 A PH 22541A PH 32596 A PH32596 A PH 32596A PH 32596 A PH32596 A PH 32596A PH 22541 A PH22541 A PH 22541A
Authority
PH
Philippines
Prior art keywords
oxazolo
quinolines
octahydro
Prior art date
Application number
PH32596A
Other languages
English (en)
Inventor
Schaus John Mehnert
Titus Robert Daniel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH22541A publication Critical patent/PH22541A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH32596A 1984-08-02 1985-08-01 Octahydro-oxazolo(4,5-g)quinolines PH22541A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63723284A 1984-08-02 1984-08-02

Publications (1)

Publication Number Publication Date
PH22541A true PH22541A (en) 1988-10-17

Family

ID=24555086

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32596A PH22541A (en) 1984-08-02 1985-08-01 Octahydro-oxazolo(4,5-g)quinolines

Country Status (19)

Country Link
EP (1) EP0172697B1 (da)
JP (1) JPH0670063B2 (da)
KR (1) KR880001430B1 (da)
AR (1) AR240822A1 (da)
AT (1) ATE67766T1 (da)
AU (1) AU569406B2 (da)
CA (1) CA1292742C (da)
DE (1) DE3584205D1 (da)
DK (1) DK349185A (da)
ES (2) ES8704499A1 (da)
GR (1) GR851895B (da)
HU (1) HU193338B (da)
IE (1) IE58695B1 (da)
IL (1) IL75991A0 (da)
NZ (1) NZ212946A (da)
PH (1) PH22541A (da)
PT (1) PT80899B (da)
SU (1) SU1421258A3 (da)
ZA (1) ZA855830B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US4939259A (en) * 1989-07-24 1990-07-03 Eli Lilly And Company 2-oxo-pyrido[2,3-g]quinoline derivatives
US6395744B1 (en) 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
JP2002518435A (ja) * 1998-06-22 2002-06-25 クイーンズ ユニバーシティ アット キングストン 女性の性機能不全の治療または改善のための方法および組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
NZ212947A (en) * 1984-08-03 1988-07-28 Lilly Co Eli Preparation of tricyclic quinoline derivatives
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines

Also Published As

Publication number Publication date
EP0172697B1 (en) 1991-09-25
AR240822A1 (es) 1991-02-28
NZ212946A (en) 1988-07-28
IE58695B1 (en) 1993-11-03
AR240822A2 (es) 1991-02-28
IE851921L (en) 1986-02-02
KR880001430B1 (ko) 1988-08-08
ES551964A0 (es) 1987-10-16
AU569406B2 (en) 1988-01-28
JPS6147487A (ja) 1986-03-07
ZA855830B (en) 1987-03-25
IL75991A0 (en) 1985-12-31
DK349185D0 (da) 1985-08-01
ES545859A0 (es) 1987-04-01
ES8800231A1 (es) 1987-10-16
HUT38348A (en) 1986-05-28
CA1292742C (en) 1991-12-03
GR851895B (da) 1985-12-03
DK349185A (da) 1986-02-03
DE3584205D1 (de) 1991-10-31
HU193338B (en) 1987-09-28
ES8704499A1 (es) 1987-04-01
EP0172697A3 (en) 1986-03-12
EP0172697A2 (en) 1986-02-26
PT80899B (pt) 1987-12-30
KR860001815A (ko) 1986-03-22
PT80899A (en) 1985-09-01
AU4573785A (en) 1986-02-06
SU1421258A3 (ru) 1988-08-30
ATE67766T1 (de) 1991-10-15
JPH0670063B2 (ja) 1994-09-07

Similar Documents

Publication Publication Date Title
CS78585A2 (en) Zpusob vyroby 1,3 disubstituovanych 2 oxindolu
GB2146993B (en) Octahydropyrimido4,5-g quinolines
PH19689A (en) 1,3-dioxolo(4,5-g)quinolines
ZA85575B (en) 1,3,2-dioxaborinanes
IL75991A0 (en) Octahydro-oxazolo(4,5-g)quinolines
GB2162175B (en) 1,8-diacyloxy-10-acylanthrones
ZA851236B (en) 2-arylimidazo 4,5-cpyridines
GB8421160D0 (en) Pyrimido(4,5-g)quinolines
GB2156353B (en) 6,6-ethylenedioxy-22r-hydroxy-2r,3s-isopropylidenedioxy-5a-cholest-23-yne
CS219684A1 (en) Sposob pripravy 1 2,6 dimetylfenoxy 2 propylaminu
IE851050L (en) OCTAHYDROTHIAZOLO £4, 5-g| QUINOLINES
EP0170822A3 (en) 2,3-dihydrobenzo-4-oxa-thiine
IE831831L (en) 1,3-DIOXOLO (4,5-g) QUINOLINES
IE840763L (en) 6-H-DIBENZ (b,e) (1,4) OXATHIEPINS
CS998884A1 (en) Derivaty l,4 dihydropyridinu
IE850681L (en) 1,2, 4 - triazacycloalkadiene
CS555184A1 (en) Sposob pripravy 1,4 benzendiol 2,3,5 trimetyl 4 acetatu
IE842726L (en) 1, 2-dithiolanes
IE842024L (en) 1,6-naphthyridines
IE841931L (en) 3-Cl-1,2,4-TRIAZOL-1-YLPROP-1-ENES
CS834384A1 (en) Zpusob vyroby 2,5 dihydroxybenzensulfonanu vapenateho
CS804584A1 (en) Zpusob pripravy oktafluor 1,3 cyklohexadienu
CS664684A1 (en) Zpusob pripravy 1,2 benzoxazolonu
CS575184A1 (en) Sposob vyroby 1,1 azobisformamidu
CS449684A1 (en) Zpusob rafinace 2,6 xylenolu